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Abstract
Background: Bacterial whole-genome sequencing (WGS) has the potential to identify reservoirs of multidrug-
resistant organisms and transmission of these pathogens across healthcare networks. We used WGS to define
transmission of vancomycin-resistant enterococci (VRE) within a long-term care facility (LTCF), and between this and
an acute hospital in the United Kingdom (UK).
Methods: A longitudinal prospective observational study of faecal VRE carriage was conducted in a LTCF in
Cambridge, UK. Stool samples were collected at recruitment, and then repeatedly until the end of the study period,
discharge or death. Selective culture media were used to isolate VRE, which were subsequently sequenced and
analysed. We also analysed the genomes of 45 Enterococcus faecium bloodstream isolates collected at Cambridge
University Hospitals NHS Foundation Trust (CUH).
Results: Forty-five residents were recruited during a 6-month period in 2014, and 693 stools were collected at a
frequency of at least 1 week apart. Fifty-one stool samples from 3/45 participants (7 %) were positive for
vancomycin-resistant E. faecium. Two residents carried multiple VRE lineages, and one carried a single VRE lineage.
Genome analyses based on single nucleotide polymorphisms (SNPs) in the core genome indicated that VRE carried
by each of the three residents were unrelated. Participants had extensive contact with the local healthcare network.
We found that VRE genomes from LTCF residents and hospital-associated bloodstream infection were interspersed
throughout the phylogenetic tree, with several instances of closely related VRE strains from the two settings.
Conclusions: A proportion of LTCF residents are long-term carriers of VRE. Evidence for genetic relatedness
between these and VRE associated with bloodstream infection in a nearby acute NHS Trust indicate a shared
bacterial population.
Background
Over the last decade the introduction of a series of in-
fection control initiatives in acute healthcare environ-
ments in the UK has been associated with a dramatic
decline in nosocomial infections caused by methicillin-
resistant Staphylococcus aureus (MRSA) and Clostridium
difficile [1, 2]. By contrast, the prevalence of bacteraemia
caused by vancomycin-resistant enterococci (VRE) has
been more resistant to change. Voluntary surveillance in
England, Wales and Northern Ireland shows that bacter-
aemia caused by vancomycin-resistant Enterococcus faecium
rose from 16 % to 24 % between 2010 and 2014 [3], with a
similar increase observed across Europe [1]. VRE infec-
tions are associated with increased morbidity, mortality,
healthcare costs and duration of hospital stay compared
with vancomycin-susceptible (VSE) infections [4, 5].
Accurate identification of VRE reservoirs and trans-
mission routes provides strategic direction to infection
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control interventions. Individuals in long-term care facil-
ities (LTCF) frequently move through healthcare networks
and are potential reservoirs for VRE [6, 7]. Pathogen
transmission between people in long-term residential and
acute care facilities is likely to be common [8], but investi-
gation is hampered by the low resolution of current typing
methods, which cannot distinguish between isolates be-
longing to the same clone [9, 10]. Whole-genome sequen-
cing (WGS) offers improved resolution, and has been
used to delineate pathogen transmission of a range of bac-
terial species at local, national and global scales [11–14].
WGS also provides the sensitivity to detect genetic diver-
sity of the same clone in an individual [15, 16]. Despite a
growing body of data, microbial WGS has not been used
to capture a dynamic picture of VRE carriage and trans-
mission within and between interconnected healthcare fa-
cilities over time. The aim of this study was to define VRE
carriage by residents of a LTCF over a 6-month period,
and to use WGS to describe the genetic relatedness of iso-
lates within and between residents, document whether
VRE was transmitted in the LTCF over time, and compare
these data with the genomes of bloodstream isolates in pa-
tients in the nearby acute hospital.
Methods
Study design, setting and participants
We conducted a prospective observational cohort study
of faecal VRE carriage in residents of a LTCF over a 6-
month period in Cambridge, United Kingdom (UK). The
LTCF had 105 beds and was subdivided into five physic-
ally separated units, to which residents were assigned
based on cognitive impairment and physical disability.
Ethics, consent and permissions
All residents admitted to the LTCF during the study
period were eligible for inclusion. Residents were ex-
cluded if they refused consent, were on an end-of-life
care pathway, or were strongly resistant to basic per-
sonal care. Written informed consent was obtained from
study participants prior to enrolment. For participants
who lacked mental capacity, we obtained assent from
their consultee. The study protocol was approved by the
National Research Ethics Service (REC ref: 13/LO/1278)
and the Cambridge University Hospitals NHS Foundation
Trust Research and Development department (ref:
A093007). All study procedures were performed in ac-
cordance with the Declaration of Helsinki.
Study procedures
Data were collected from medical records and nursing
care plans. This included demographics (age, gender,
unit of residence), presence of co-morbidities (Charlson
co-morbidity Index), presence of urinary or faecal incon-
tinence or a urinary catheter, a history of VRE carriage
or infection in the 12 months prior to enrolment, and
infection and antibiotic use during the study. Data were
also collected on healthcare contact (inpatient admis-
sion, outpatient clinic attendance, or general practitioner
(GP) surgery visit) in the 12 months prior to enrolment
and during the study period. Stool samples were col-
lected at recruitment and then repeatedly (up to once a
week) until the end of the study period, discharge from
the LTCF or death.
Laboratory procedures
Stool samples were cultured within 24 h of collection on
Monday to Friday, or within 48 h if collected at week-
ends. A 10 μL loopful was added to 5 mL Brain-Heart
Infusion Broth (BHI) (Merck, Darmstadt, Germany) con-
taining 3 μg/mL vancomycin (Sigma-Aldrich, St Louis,
MO, US) and incubated at 37 °C in air at 100 rpm for 24
h. A total of 200 μL was plated onto Brilliance VRE agar
(Oxoid, Basingstoke, UK) and incubated at 37 °C for 48
h. Purple or blue colonies (putative E. faecium or E.
faecalis, respectively) were sub-cultured on Columbia
Blood agar (CBA, Oxoid, Basingstoke, UK), incubated at
37 °C for 48 h, and the species confirmed using matrix-
assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF) (Bruker Daltoniks, Bremen,
Germany). Antimicrobial susceptibility was determined
using the Vitek2 instrument (BioMérieux, Marcy l’Etoile,
France) and the AST-P607 card. All stools positive for
VRE were cultured for VSE. A 10 μL loopful was plated
onto Brilliance UTI agar (Oxoid, Basingstoke, UK). Pre-
sumptive enterococci were sub-cultured on CBA con-
taining a 5 μg vancomycin disc (Oxoid, Basingstoke,
UK). Colonies growing at the edge of the zone of inhib-
ition were selected for identification and antimicrobial
susceptibility testing as above.
Bacterial sequencing and analysis
Genomic DNA was extracted from a pure bacterial
culture based on a single colony using the QIAxtractor
(QIAgen, Hilden, Germany). Library preparation was
based on the Illumina protocol, and sequencing was per-
formed on an Illumina HiSeq2000 with 100-cycle paired-
end runs. Sequence reads were assembled using Velvet
and mapped to the E. faecium reference genome Aus0004
(European Nucleotide Archive (ENA) accession number
CP003351) using SMALT [17]. Mobile genetic elements
(MGEs) were identified (genes annotated as plasmid-,
phage-, IS- or transposon-associated) and removed.
Gubbins was used to remove regions of recombination [18],
creating a core genome. Core genome single nucleotide
polymorphisms (SNPs) were used to estimate maximum
likelihood trees using RAxML [19] with 100 bootstraps
and a midpoint root. The multilocus sequence type (ST)
was derived from sequence data using an in-house script
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and the MLST database [20]. vanA and vanB were de-
tected by in silico polymerase chain reaction (PCR) using
published primers [21, 22]. Isolates positive for vanA were
mapped to a Tn1546 reference (ENA accession number
M97297). The nucleotide sequences of the Tn1546 trans-
poson, and those up- and downstream of the transposon,
in each isolate were identified as described by Howden et
al. [23] using Artemis [24], and queried against each other
and nucleotide databases using BLAST. Isolates positive
for vanB were mapped to Aus0004 Tn1549 [25] and up-
and downstream nucleotide sequences identified as for
vanA. Plasmid replicon (rep) typing was performed using
in silico PCR and published primers [26, 27].
Whole-genome sequences were available for 45 E.
faecium bloodstream isolates collected between January
and December 2012 at the Cambridge University
Hospitals NHS Foundation Trust (CUH) (S. Peacock,
personal communication). These consisted of the first
stored isolate for 45 patients, identified using the diag-
nostic microbiology laboratory database at CUH. Infor-
mation on date of isolation and patient location was
available. These isolates had been sequenced as part of
a previous study, approved by the National Research
Ethics Service (REC ref: 12/EE/0439) and the Cambridge
University Hospitals NHS Foundation Trust R&D
Department (ref: A092685). Sequence data for all
study isolates have been submitted to the European
Nucleotide Archive with the accession numbers shown in
Additional file 1.
Results
Baseline characteristics
Forty-five of the 90 (50 %) eligible residents were re-
cruited. Participants had a median age of 82 years
(range, 40–104 years; interquartile range (IQR), 71–87
years), and 29 (64 %) were female. Three participants
were lost to follow-up during the study because of death
(n = 2) or transfer to another facility (n = 1). The median
duration of residence in the study facility at the time of
recruitment was 16 months (range, 5 days to 54 months;
IQR, 6–41 months). The median Charlson co-morbidity
Index was 6 (range, 0–10). Thirty-three (73 %) partici-
pants were incontinent of urine and faeces (three of whom
had an indwelling urinary catheter), and two (5 %) partici-
pants had urinary incontinence alone. One participant
(P7) had a history of VRE infection (of the urinary tract)
in the 12 months prior to recruitment.
The majority of residents (38/45, 85 %) had previously
resided in another healthcare facility. Movement of par-
ticipants through the healthcare network is summarised
in Table 1. Healthcare contact was extensive, with more
than half of participants (n = 26, 58 %) having at least
one episode of healthcare contact (hospital admission,
outpatient clinic attendance or visit to a GP surgery) in
the 12 months prior to recruitment, and six participants
having between 1 and 5 (total of 19) episodes of health-
care contact during the study. There were 61 infections
recorded in 23 (51 %) participants (median, 2 infections
per case; range, 1–5) during the 6-month study period,
although none of these were associated with VRE. The
most common site of infection was the urinary tract
(n = 33, 54 %), followed by respiratory tract (n = 16) and
skin and soft tissue infection (n = 8). The focus of infec-
tion in four cases was not specified. All participants
with a urinary catheter had at least one urinary tract in-
fection recorded during the study period. The 23 partic-
ipants received 63 courses of antibiotics (median, 2
courses; range, 1–6).
Carriage of vancomycin-resistant E. faecium by study
participants
A total of 693 stools were collected over the 6-month
study period, at a frequency of at least 1 week apart.
Fifty-one stools from three participants (7 %) were posi-
tive for VRE, all of which were E. faecium (n = 24, 21
and 6 positive samples for P7, P15 and P31, respect-
ively). This included the participant (P7) who had a past
history of VRE infection. Figure 1a shows the timing of
positive and negative samples for each of the three cases.
STs of the 51 VRE isolates were identified from the se-
quence data, which assigned the isolates to six STs
Table 1 Summary of healthcare contact for 45 study
participants
Healthcare contact Frequency
Place of residence before admission to study facility (n, %)
Home 7 (46.7 %)
Hospital 17 (37.8 %)
Residential carea 21 (15.6 %)
Participants with healthcare contact 12 months before
recruitment (n, %)
26 (57.7 %)
Total number of episodes 60
Median (range) per participant 2 (1–4)
Inpatient admissionb 23/60 (38.3 %)
Outpatient attendancec 35/60 (58.3 %)
General practice attendanced 2/60 (3.3 %)
Participants with healthcare contact during study (n, %) 6 (13.3 %)
Total number of episodes 19
Median (range) per participant 2 (1–5)
Inpatient admissionb 8
Outpatient attendancec 11
General practice attendanced 0
aResidential care – any nursing or residential home
bAdmission to hospital for at least an overnight stay
cOutpatient department visit or visit to emergency department not resulting
in admission
dVisit to GP surgery
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(ST18, ST80, ST117, ST203, ST780 and ST787). A not-
able feature was that two residents (P7 and P15) each
carried multiple STs with no overlap in STs between the
two cases: P7 carried ST80 (isolated from 20 stool sam-
ples), ST117 (n = 2), and ST203 (n = 2), and P15 carried
ST787 (isolated from 18 stool samples), ST18 (n = 2),
and ST780 (n = 1). The third VRE positive resident (P31)
carried a single ST that was assigned to ST203. In silico
PCR demonstrated that the 51 VRE isolates carried
vanA.
A phylogenetic tree for the 51 VRE isolates based on
SNPs in the core genome is shown in Fig. 1b. P7 carried
four genetically distinct lineages (two of which belonged
to ST80), and P15 carried three, with no evidence for
carriage of related strains by these two residents. The
majority of VRE isolates from P7 and P15 each belonged
to a single lineage (18/24 (75 %), and 18/21 (86 %)), with
a median pairwise SNP difference within each of these
two clusters of 3 (range, 0–6) and 1 (range, 0–6), re-
spectively. P7 and P31 both carried VRE isolates belong-
ing to ST203, but these were genetically distinct (median
SNP difference of 74; range, 73–74), excluding transmis-
sion between them (Fig. 1b). The VRE-positive partici-
pants resided in different units. All three VRE positive
participants had healthcare contact in the 12 months
prior to the study, including hospital admission (5 epi-
sodes), outpatient clinic attendance (3 episodes) or at-
tendance at Accident and Emergency Department
without admission (1 episode), and one VRE positive
participant (P7) had healthcare contact during the study
1 32 4 5 6 7 8 9 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 2710
P7
P31
P15
A
B
70 .0 SNPs
P7-W15
-ST117
P
31
-W
3-
S
T
20
3
P15-W8-ST787
P15-W3-ST787
P15-
W23
-ST7
80
P7-W
16-ST
117
P7-W
10-S
T80
P
7-W
20-S
T
203
P
15-W
7-S
T787
P
15-W
19-S
T
787
P7
-W
11-
ST
80
P
31
-W
4-
S
T2
03
P7-W5-ST80
P
15-W
18-S
T787
302T
S-11
W-13
P
P7-W1-ST80
P7
-W
18
-S
T8
0
P15-W
13-ST787
P
7-
W
14
-S
T8
0
30
2
T
S-
91
W-
7
P
P7-W26
-ST80
P15-W4-ST18
P7
-W
2-
ST
80
P15-W1-ST787
P7-W
17-ST
80
P15-W15-ST787
P15-W
14-ST787
P
31
-W
5-
S
T2
03
P15-W
16-ST787
P15-W10-ST787
P15-W17-ST787
P7-
W7
-ST
80
P7-W23-ST
80
P15-W
5-ST787
P7-W22-ST80
P15-W11-ST787
P7
-W
3-
ST
80
P15-W
6-ST787
P
31-W
10-S
T
203
P7
-W
12
-ST
80
P
31
-W
6-
S
T
20
3
P7-W9-ST80
P15-W20-ST18
P15-W
2-ST787 P
7-
W
6-
ST
80
P7
-W
21
-S
T8
0
P15-W12-ST787
P7
-W
8-S
T8
0
P
15-W
9-S
T787
P7-W4-ST80
P7-
W1
3-S
T80
Aus0004
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consisting of four inpatient admissions and five out-
patient clinic attendances.
To identify the genomic location of the vanA transposon
and its relatedness within and between participants, we
analysed the region of sequence adjacent to the transposon
in each isolate. This was possible for 30 isolates from the
three participants and included four STs (ST80, 117, 203
and 787). The highest match in the blast database predicted
that the transposon was present on the pLG1 mega-
plasmid (accession numbers HM565234 and HM565172)
[28] for 29/30 isolates, (100 % ID up to 5998 bp) and was
adjacent to a gene encoding a cadmium efflux system
accessory protein. Blast analysis of the remaining isolate
(from P15) gave multiple matches to regions in E. faecium
strain DO plasmid 2 (accession number CP003585) [29],
p5753cB (GQ900487) [30], pS177 (HQ115078) [31], pF856
(JQ663598) [32] and pRUM (AF507977) [33]. To analyse
the similarity between the putative pLG1 plasmid transpo-
sons, sequence reads for the 29 genomes were mapped to a
reference vanA transposon. This revealed that the six ge-
nomes from P31 isolates shared 100 % identity with the ref-
erence, while 23 isolates from P7 were identical with the
exception of the same SNP at position 8634. We also char-
acterised variation in plasmids using rep typing, which
demonstrated the presence of seven types (10, 11, 14, 17,
18, 20 and pMG1) with a range of 2–7 rep types per isolate.
There was variation in the presence of rep types, both
within and between individual STs, which extended to vari-
ation within the same individual.
Genetic relatedness between vancomycin-resistant
and -susceptible E. faecium
All 51 VRE-positive stools were cultured for the pres-
ence of VSE, which was identified in 25 (49 %) stools
from the three participants (n = 9, 15 and 1 for P7, P15
and P31, respectively). MLST was identified from the se-
quence data, which assigned the isolates to nine STs. As
before, P7 and P15 carried multiple STs: P7 carried
ST80, ST117 and ST203 (mirroring the VRE STs in this
individual) together with ST127 (a single locus variant of
ST80), while P15 carried ST787 and ST18 (mirroring
the VRE STs in this individual), together with two STs
not represented in the VRE population (ST206 and
ST17). By contrast, the VSE carried by P31 was assigned
to an ST that was different from their VRE strain
(ST328). Rep typing of the VSE isolates revealed the
same rep types found in the VRE isolates, with a median
of 6 rep types per isolate (range, 2–7). No rep types were
specific to VRE or VSE. One phenotypically vancomycin
susceptible isolate carried the vanB gene (P15-week(W)12-
ST17) based on in silico PCR. This isolate lacked the vanR
and vanS genes from whole genome sequence data and
from the assembled Tn1549 transposon. Loss of vanR
and vanS from the van operon resulting in a susceptible
phenotype has been described previously for vanA-posi-
tive isolates [32, 34]. A phylogenetic tree of the 51 VRE
and 25 VSE isolates based on core genome SNPs is shown
in Additional file 2. This showed that the VSE carried by
P7 and P15 were closely related to their resident VRE pop-
ulations demonstrating possible in vivo acquisition or loss
of resistance, whilst as expected the VSE carried by P31
was not closely related to their VRE.
Relatedness of E. faecium within a healthcare network
Sequence data for VRE isolates from study participants
were compared with that for 45 E. faecium isolates from
patients with bloodstream infection at the nearby acute
hospital during 2012. Phenotypic susceptibility testing
demonstrated that 41 isolates were vancomycin-resistant
(all of which carried vanA), and four isolates were
vancomycin-susceptible. A phylogenetic tree of the 51
VRE from stool and 45 hospital isolates based on core
genome SNPs showed that carriage isolates from the
three study participants were interspersed throughout
the tree (Fig. 2a). There were several examples where
isolates from the LTCF and hospital were highly related
(Fig. 2b and c) which included two sets of isolates from
P15 and one from P7. One of these clusters included
two VRE isolates from P7 that were closely related to six
hospital-associated VRE bloodstream isolates cultured in
2012 (minimum pairwise SNP difference of 4; range, 4–15)
and one from P15 with a minimum pairwise SNP difference
of 6 (Fig. 2b). P7 was not admitted to CUH during 2012,
but was admitted twice during 2013 (for 1.5 and 2 months,
respectively) and was also admitted to CUH on four further
occasions during the study period. Comparison of transpo-
sons and sequences downstream of their insertion between
the LTCF and hospital isolates was possible for five of these
six hospital isolates. This revealed that the transposon se-
quences and downstream sequences for 4/5 were identical
to the two isolates from P7. The fifth hospital isolate had
two SNPs and an 89 bp insertion in the sequence down-
stream of the transposon. A second cluster involved VRE
carried by P15 and VRE bloodstream isolates from two pa-
tients, the closest of which also differed by six SNPs
(Fig. 2c). A case note review revealed that P15 was admitted
to the CUH on three occasions in 2012, and had
ampicillin-resistant E. faecium isolated from urine during
the third admission. P15 was an inpatient at the same time,
but not on the same ward as the two patients with
bloodstream infection in this cluster (Fig. 2c). The four
vancomycin-susceptible isolates were found to be carrying
vanB by in silico PCR. Additionally, we noted that the sin-
gle isolate positive for vanB isolated from P15 clustered
with the four vanB positive hospital-associated blood-
stream isolates, the closest of which was 12 SNPs different
based on a core genome comparison. Mapping of these
isolates to the Aus0004 Tn1549 transposon demonstrated
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that the transposons and their downstream sequences
were identical to that of the vanB-positive isolate from the
LTCF.
Discussion
Residents of LTCFs are at increased risk of infection
from a range of multidrug-resistant organisms (MDRO)
compared with the general population [35, 36]. This may be
related to several factors, including frequent healthcare con-
tact and high levels of antibiotic use. Furthermore, LTCF
are often akin to a home environment, where screening for
MDROs is not routinely performed and isolation of resi-
dents may be detrimental to care. The combination of these
factors represents a perfect storm for the control of MDRO.
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In this study, we focused on carriage and transmission
of VRE, a nosocomial pathogen that has remained a
persistent problem despite the raft of infection control
measures introduced into UK hospitals to reduce the
prevalence of MRSA and C. difficile. We found that 7 %
of residents carried VRE in their stool on at least one oc-
casion, a finding consistent with previous studies in
Israel, Germany and the United States [6, 7, 37]. Our
longitudinal study design allowed us to investigate car-
riage over time. This identified variability in the duration
of carriage, with two long-term carriers and one individ-
ual who appeared to lose VRE carriage during the study.
Intermittent and transient VRE carriage has been de-
scribed previously [38, 39]. Genome sequencing was
used to determine the genetic relatedness of VRE iso-
lates. The advantage of doing so became apparent on
comparing this with the results of in silico MLST. Reli-
ance on MLST could have led to an incorrect link being
made between two residents (P7 and P31) who both car-
ried VRE ST203 which were not closely related on
sequencing.
Sequencing of VSE in VRE-positive participants dem-
onstrated that two individuals carried multiple VSE line-
ages that were closely related to their VRE isolates. This
is consistent with the findings of Howden et al. [23] that
VRE and VSE across the species are not genetically dis-
tinct. VSE strains may have gained resistance via hori-
zontal gene transfer from colonising VRE lineages. We
identified identical vanA transposons and insertion sites
in multiple STs from P7, suggesting possible sharing of
the vanA mobile genetic element within patients. Rep
types were not distinct between VRE and VSE popula-
tions, and varied within STs, suggesting the presence of
highly mobile plasmids.
A combination of epidemiological and sequence data
allowed us to consider the source of VRE acquisition.
While the LTCF environment might be expected to lead
to multiple transmission events, there was no evidence
for direct transmission of VRE within the study facility.
Prior evidence for transmission of VRE in LTCFs is lim-
ited, with a single point prevalence study suggesting
transmission between 3/188 residents based on pulse
field gel electrophoresis [40]. Instead, the source of ac-
quisition may be linked to the frequent interaction with
healthcare facilities as two persistent carriers with a his-
tory of extensive healthcare contact carried multiple
VRE lineages, the majority of which have been associ-
ated previously with the healthcare setting based on
MLST [41]. This indicates long-term carriage (over 6
months) of hospital-associated lineages in community-
based care facilities.
Comparison of WGS data for VRE from the LTCF and
the acute hospital to which the participants are referred
provided the opportunity to compare the relatedness of
isolates drawn from different parts of the same healthcare
network. This demonstrated that isolates associated with
bloodstream infection were highly related to those carried
by the LTCF residents. Direct transmission between the
study participants and hospital patients is unlikely, but
two of the participants carrying VRE were admitted to the
hospital within a relevant timeframe for exposure to the
circulating VRE lineages. Furthermore, repeated admission
of the study participants represents a mechanism for per-
petuation of these lineages. The sequence downstream of
the vanA transposon in two of the LTCF isolates was iden-
tical to four of five hospital isolates closely related to them,
providing further evidence for transmission of VRE from
hospitals to community care facilities. Additionally, this
region of sequence in the genetically more stable vanB
Tn1549 transposon of the LTCF isolate matched those
from the hospital also carrying vanB.
Our study has several limitations. First, only half of
the residents in the study facility agreed to participate in
the study, which may have obscured transmission events
between study participants and individuals who were not
recruited. Second, we only sequenced a single colony
from each stool sample, which may have affected our
ability to detect carriage of more than one VRE lineage.
However, this risk was mitigated by repeated sampling
of individual patients over time, which did demonstrate
carriage of multiple lineages in long-term carriers. Evi-
dence for concurrent carriage of multiple HCA lineages
of enterococci is limited, but has implications for current
screening and WGS techniques based upon single cul-
tures. Finally, we only had access to the genome se-
quence of bloodstream isolates from the acute hospital,
which may not be fully representative of the carriage
population in this setting. Despite this, we were still able
to provide evidence demonstrating that clones had been
shared between the hospital and LTCF.
Conclusions
This study has confirmed that a proportion of residents in
a community-based long-term care facility carried VRE in
stool, genome sequencing of which demonstrated multiple
lineages in some cases but no evidence for transmission
between residents. This population frequently requires ad-
mission to hospital, where they may acquire nosocomial
pathogens as well as transmit existing strains to hospital
patients and shed organisms into the environment. A gen-
ome comparison of VRE carriage isolates in the LTCF and
VRE bloodstream isolates confirmed that VRE in the two
populations were highly related. This shared population is
likely to reflect two-way transmission. Tackling multidrug-
resistant pathogens in hospitals requires an understanding
of reservoirs and transmission of bacteria within highly
connected healthcare facilities, together with infection
control policies that consider this as a continuum.
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